Cannabis companies reveal trade secret conundrums In-house and private practice sources say the need to protect confidential information can clash with state public record laws and a history of freely sharing information in the industry By Rani Mehta February 28 2020
Nike, the Olympics and shoetech: the need for speed – and innovation Patent attorney Phil Jeffrey examines the potential IP implications of Nike’s latest running shoes and whether the company’s competitors might pool together before the Tokyo Olympics By Managing IP Correspondent February 28 2020
Confirmed: UK to shun unitary patent and UPC The government says that UPC membership and CJEU oversight would be inconsistent with its objective of being a self-governing nation By Max Walters February 28 2020
Why financials don’t care if covered business methods are extended With the PTAB’s CBM programme due to expire in September, counsel at financials say they might like to see its life prolonged, but only if its usefulness were to be restored By Patrick Wingrove February 27 2020
EU pay-for-delay ruling ‘prevents cooperation and market sharing’ The recent decision in Generics v Competition and Markets Authority from the CJEU is too restrictive and will result in higher litigation costs, say pharma sources By Charlotte Kilpatrick February 27 2020
PTAB rankings: the top petitioners, patent owners and law firms in 2019 Apple keeps top petitioner status, Uniloc is the top patent owner and Fish & Richardson remains the law firm working on most disputes for a third year in a row, according to PTAB data revealed by Managing IP By Patrick Wingrove February 26 2020
EPO exams: to change or not to change? With the qualification process for UK attorneys being reviewed, lawyers in France, Germany and the UK ask whether the European system also needs an overhaul By Max Walters February 26 2020
China IP Forum: Punitive damages remain a sticking point for judges Leading IP judges and academics discuss challenges and opportunities in developing punitive damages and in enforcement By Karry Lai February 24 2020
KnowIt comes to Las Vegas KnowIt: Intellectual Property in a Digital World will be held at Aria Resort and Casino in Las Vegas between May 11-14. It will cover a number of panel discussions on various IP issues including AI, privacy and the et... By Sanjana Kapila February 21 2020
Biologics post-grant review surge stemmed by estoppel In-house counsel say that while PGRs offer several advantages over other PTAB post-grant proceedings, they cost more, require more organisation and severely limit further litigation By Patrick Wingrove February 20 2020
UK attorneys at odds over exams overhaul In-house and private practice patent attorneys welcome a review of the “notoriously difficult” qualification process but worry it could be a missed opportunity By Max Walters February 19 2020
China IP Forum: Pitfalls to monitor as Chinese tech firms expand globally In-house counsel at China Literature, SenseTime and iQiyi say copyright infringement and export control rules are keeping them awake at night By Karry Lai February 18 2020
PTAB petition fall tied to broad litigation trends Lawyers at Unified Patents, 3M and a telecoms company say that while a 23% application fall in 2019 highlights the increased risk of filing at the PTAB, the numbers could bounce back By Patrick Wingrove February 17 2020
TC Heartland still stifles plaintiffs and foreign firms Although some US in-house counsel say three years has been enough time to adjust to the venue shopping ruling, others are still feeling the pinch By Patrick Wingrove February 14 2020
EPO decision creates AI inventorship uncertainty Questions about AI inventorship remain after the EPO publishes its justification for refusing two patent applications for machine inventors By Charlotte Kilpatrick February 14 2020
The importance of mentorship for women in IP Female IP professionals tell Managing IP about their experience of mentorship and give tips on how to choose the best career advisors By Charlotte Kilpatrick February 13 2020
STEM women must be more visible, say in-house experts In-house lawyers in the pharma, IT and software industries, and those in private practice, say female role models must be encouraged if a new generation of women is to flourish in STEM roles By Max Walters February 12 2020
How to talk money and patents with your C-suite (open access) Counsel at the MIP International Women’s Leadership Forum 2020 gave trusted advice for talking patents with a brand-focused C-suite By Charlotte Kilpatrick February 11 2020
China IP Forum: Supreme Court IP vice president calls for punitive damages focus Wang Chuang also sheds light on the trend to combine civil and administrative cases, and the development of the talent pipeline By Karry Lai February 11 2020
Patent eligibility reform high on agenda but not expected this year With the US Supreme Court rejecting three Section 101 petitions and a presidential election underway, pro-reform businesses have little hope for an eligibility remedy in 2020 By Patrick Wingrove February 07 2020
Brexit: UK pharma fears international IP exhaustion scheme Pharma in-house counsel say an international IP exhaustion framework could undercut the UK drugs market and create shortages in other parts of the world By Charlotte Kilpatrick February 06 2020
US-China trade deal step in right direction but more work needed US-based in-house and private practice counsel say the deal’s first phase should improve relations with Chinese patent owners and make cross-licensing and innovation easier By Patrick Wingrove February 06 2020
Managing IP Americas Awards 2020 shortlists announced Managing IP reveals the shortlists for the Americas Awards 2020 ceremony, which will be held on March 26 at the Lotte New York Palace, New York City By Kingsley Egbuonu February 05 2020
Opinion: is there a conflict between open source and standards? Adrian Howes, head of IP and standards at Nokia, says software and standards development are complementary activities but that work on each should be kept separate in view of licensing differences By Managing IP Correspondent February 04 2020
Managing IP’s most-read stories in January 2020 (free) An assessment of Europe’s IP market, a strategy ‘bonfire’ and an insight into returning to work after parental leave were among our most-read stories last month By Max Walters February 04 2020
US-China phase one trade deal draws curiosity from IP counsel In-house counsel from a range of sectors have high hopes for the expected IP changes but want to see more details before they get too comfortable By Karry Lai February 04 2020
Biologics litigation raises remedy and external counsel concerns With innovator-v-innovator cases growing, in-house counsel say they cannot always rely on trusted tactics for small molecule litigation, or even on some of their trusted law firm partners By Patrick Wingrove February 03 2020
German patent law draft divides owners and implementers In-house counsel from automotive, telecoms and tech companies are split on proposed changes that seek to close the injunction gap and give judges more discretion to grant automatic injunctions By Charlotte Kilpatrick February 03 2020
